Wells Fargo upgraded DuPont from Equal Weight to Overweight and set a new price target of $103.00 from $80.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/7/2024 | $88.00 → $84.00 | Equal Weight → Underweight | Barclays |
| 5/28/2024 | $85.00 → $95.00 | Neutral → Buy | Citigroup |
| 5/24/2024 | $80.00 → $103.00 | Equal Weight → Overweight | Wells Fargo |
| 5/23/2024 | $96.00 | Market Perform → Outperform | BMO Capital Markets |
| 5/17/2024 | $78.00 → $101.00 | Hold → Buy | Jefferies |
| 3/1/2024 | Peer Perform | Wolfe Research | |
| 1/24/2024 | $85.00 → $69.00 | Overweight → Equal Weight | Wells Fargo |
| 1/24/2024 | $80.00 → $72.00 | Outperform → Market Perform | BMO Capital Markets |
Providing a diverse range of perspectives from bullish to bearish, 11 analysts have published ratings on DuPont de Nemours (NYSE:DD) in the last three months. The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 6 3 2 0 0 Last 30D 1 0 0 0 0 1M Ago 0 0 0 0 0 2M Ago 4 2 1 0 0 3M Ago 1 1 1 0 0 Analysts have recently evaluated DuPont de Nemours and provided 12-month price targets. The average target is $93.09, accompanied by a high estimate of $103.00 and a low estimate of $81.00. Observ
Citigroup analyst Patrick Cunningham maintains DuPont de Nemours (NYSE:DD) with a Buy and lowers the price target from $95 to $94.
DuPont de Nemours's (NYSE:DD) short percent of float has risen 3.31% since its last report. The company recently reported that it has 5.75 million shares sold short, which is 1.56% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.73 days to cover their short positions on average. Why Short Interest Matters Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises. Short interes
SC 13G/A - DuPont de Nemours, Inc. (0001666700) (Subject)
SC 13G/A - DuPont de Nemours, Inc. (0001666700) (Subject)
SC 13G - DuPont de Nemours, Inc. (0001666700) (Subject)
Net Sales of $3.2 billion increased 4%; organic sales increased 3% versus year-ago periodGAAP Income from continuing operations of $480 million; operating EBITDA of $857 millionGAAP EPS from continuing operations of $1.13; adjusted EPS of $1.18Cash provided by operating activities from continuing operations of $737 million; transaction-adjusted free cash flow of $640 millionRaises guidance for full year 2024 operating EBITDA and adjusted EPSWILMINGTON, Del., Nov. 5, 2024 /PRNewswire/ -- DuPont (NYSE:DD) announced its financial results(1) for the third quarter ended September 30, 2024.
WILMINGTON, Del., Oct. 17, 2024 /PRNewswire/ -- DuPont (NYSE:DD) will release its third quarter 2024 financial results at 6:00 a.m. ET on Tuesday, November 5, 2024. In addition, the company will host a conference call at 8:00 a.m. ET that day. The event will be webcast live and can be accessed on DuPont's Investors Relations webpage. A replay, along with the earnings release and supporting materials, will also be posted to the website. The dial-in number for the conference call is 888-440-4172 toll-free within the U.S. or +1-646-960-0673. The conference ID is 5994046. About Du
WILMINGTON, Del., Oct. 16, 2024 /PRNewswire/ -- DuPont (NYSE:DD) today announced that its Board of Directors has declared a quarterly dividend of thirty-eight cents ($0.38) per share on the outstanding Common Stock of the Company (par value $0.01 per share) payable on December 16, 2024, to holders of record of said stock at the close of business on November 29, 2024. About DuPontDuPont (NYSE:DD) is a global innovation leader with technology-based materials and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help
Barclays downgraded DuPont from Equal Weight to Underweight and set a new price target of $84.00 from $88.00 previously
Citigroup upgraded DuPont from Neutral to Buy and set a new price target of $95.00 from $85.00 previously
Wells Fargo upgraded DuPont from Equal Weight to Overweight and set a new price target of $103.00 from $80.00 previously
4/A - DuPont de Nemours, Inc. (0001666700) (Issuer)
4/A - DuPont de Nemours, Inc. (0001666700) (Issuer)
4 - DuPont de Nemours, Inc. (0001666700) (Issuer)
10-Q - DuPont de Nemours, Inc. (0001666700) (Filer)
8-K - DuPont de Nemours, Inc. (0001666700) (Filer)
S-3ASR - DuPont de Nemours, Inc. (0001666700) (Filer)
Dr. Deyan Wang and Nicholas Sands Recognized for a Career of Innovation and Business Impact; Achieve Highest Technical Level in the Company WILMINGTON, Del., Oct. 10, 2024 /PRNewswire/ -- DuPont (NYSE:DD) today announced that two of its technology leaders have achieved the professional distinction of DuPont Laureate, the company's most distinguished technical designation. The newly appointed Laureates are Dr. Deyan Wang, DuPont Electronics & Industrial and Nicholas (Nick) Sands of DuPont Water & Protection. "I'm tremendously honored to recognize Deyan and Nick, two of DuPont's
Transaction deepens healthcare offerings in medical device solutions WILMINGTON, Del., June 25, 2024 /PRNewswire/ -- DuPont (NYSE:DD) today announced it has signed an agreement to acquire Donatelle Plastics Incorporated, a leading medical device contract manufacturer specializing in the design, development and manufacture of medical components and devices. The transaction is expected to close in the third quarter 2024, subject to satisfaction of customary closing conditions and receipt of regulatory approvals. "Our healthcare strategy is focused on offering a comprehensive sui
Ed Breen to Transition to Executive Chair Role; Lori Koch Named Chief Executive Officer; Antonella Franzen Named Chief Financial Officer WILMINGTON, Del., May 22, 2024 /PRNewswire/ -- DuPont (NYSE:DD) today announced that its Board of Directors has selected Lori D. Koch, DuPont's Chief Financial Officer, to succeed Edward D. Breen as the company's Chief Executive Officer. Effective June 1, 2024, Mr. Breen will transition from the role of CEO to full-time Executive Chairman of the Board of Directors. Additionally, Ms. Koch is expected to join the Board of Directors at its next regularly scheduled meeting in June.
ATLANTA, Nov. 14, 2024 /PRNewswire/ -- Habitat for Humanity International and DuPont today announced they are renewing their annual global partnership. As part of the collaboration, DuPont will donate products to local Habitat for Humanity affiliates as well as provide cash donations that support employee volunteer builds around the world. In 2023, DuPont committed $400,000 to support local Habitat for Humanity affiliates near DuPont offices and plants, benefiting communities across the U.S., Canada, Mexico, Singapore, and South Korea. In addition, DuPont donated more than $60
MUNICH, Nov. 12, 2024 /PRNewswire/ -- As the demand for advanced technology surges, DuPont will be featuring its extensive portfolio of innovative products and solutions at Electronica 2024, the world's premier trade fair for electronics, November 12-15 in Munich. Meet us at the nexus of innovation: Hall B3, Stand Number 562 and discover our transformative vision for the electronics landscape under the banner: "One Stop Powerhouse for Advanced Interconnect and Thermal Management." "Electronica 2024 is a pivotal platform for showcasing our commitment to innovation in the electronics sector," said Sebastien Chaudet, Europe General Manager for DuPont Interconnect Solutions. "We're eager to conn
WILMINGTON, Del., Nov. 7, 2024 /PRNewswire/ -- DuPont (NYSE:DD) today announced the launch of Tyvek® with Renewable Attribution (RA), an extension of the existing portfolio of Tyvek® products for healthcare packaging that offers a significantly reduced carbon footprint, helping to enable more sustainable healthcare packaging. The carbon footprint reduction for Tyvek® with Renewable Attribution is enabled by the partial replacement of fossil fuel feedstock with certified bio-circular feedstock during the production of raw materials used in Tyvek® manufacturing. This is achieved through the mass balance approach, in accordance with International Sustainability and Carbon Certification (ISCC P